Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies

PK Garg, HS Bhatia, TS Allen, T Grainger… - … and Vascular Biology, 2024 - Am Heart Assoc
BACKGROUND: One strategy to reduce the burden of cardiovascular disease is the early
detection and treatment of atherosclerosis. This has led to significant interest in studies of …
被引用次数：3 相关文章

Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies.

PK Garg, HS Bhatia, TS Allen, T Grainger… - … and Vascular Biology, 2023 - europepmc.org
One strategy to reduce the burden of cardiovascular disease is the early detection and
treatment of atherosclerosis. This has led to significant interest in studies of subclinical …

Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies

PK Garg, HS Bhatia, TS Allen… - Arteriosclerosis …, 2024 - pubmed.ncbi.nlm.nih.gov
Background One strategy to reduce the burden of cardiovascular disease is the early
detection and treatment of atherosclerosis. This has led to significant interest in studies of …

Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies

PK Garg, HS Bhatia, TS Allen… - Arteriosclerosis …, 2023 - ingentaconnect.com
BACKGROUND: One strategy to reduce the burden of cardiovascular disease is the early
detection and treatment of atherosclerosis. This has led to significant interest in studies of …